Wire flash
Baihua Pharmaceutical's top trading seats net sell 41.7 mln yuan on Sept 24
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
According to data from the Shanghai Stock Exchange, Baihua Medicine (百花医药) appeared on the 'Dragon and Tiger List' on September 24 due to a daily turnover rate of 39.69%. The top five buying and selling brokerage departments combined for a total turnover of 499 million yuan, with buy-side transactions at 229 million yuan and sell-side at 270 million yuan, resulting in a net sell-off of 41.7 million yuan. The largest buyer and seller was Guotai Haitong Securities. Over the past six months, the stock has appeared on the list 31 times, with an average price increase of 0.74% the day after listing and 1.08% after five days. On the day, the stock saw a net inflow of 41.4 million yuan from major funds, including 42.5 million yuan from very large orders. The company's semi-annual report released on August 25 showed a 22.13% year-on-year decline in revenue to 157 million yuan and a 42.08% drop in net profit to 14.76 million yuan.
Source report
Shanghai Stock Exchange public data shows that the stock was listed on the exchange's daily ranking due to a turnover rate of 39.69%. The combined net sell-off from brokerage seats amounted to RMB 41.7019 million.
According to data from Securities Times · Data Bao, the top five buying and selling brokerage seats recorded a total transaction volume of RMB 499 million. Among this, buy-side transactions totaled RMB 229 million, while sell-side transactions reached RMB 270 million, resulting in a net sell-off of RMB 41.7019 million.
Specifically, both the largest buying and selling seats were from Guotai Haitong Securities.
Over the past six months, the stock has appeared on the Dragon and Tiger Board 31 times. On average, the stock price rose 0.74% on the day following its listing, and 1.08% within five days after listing.
In terms of capital flow, the stock saw a net inflow of RMB 41.3973 million from major funds today, including a net inflow of RMB 42.5099 million from very large orders and a net outflow of RMB 1.1126 million from large orders. Over the past five days, the net inflow from major funds totaled RMB 278 million.
According to the semi-annual report released by the company on August 25, the company achieved total operating revenue of RMB 157 million in the first half of the year, a year-on-year decrease of 22.13%, and net profit of RMB 14.7603 million, a year-on-year decrease of 42.08%.
Baihua Pharmaceutical Trading Information on September 24
| Buy/Sell | Brokerage Seat Name | Buy Amount (RMB 10,000) | Sell Amount (RMB 10,000) | |---|---|---|---| | Buy 1 | Guotai Haitong Securities Co., Ltd. Headquarters | 10,034.47 | | | Buy 2 | Huatai Securities | 4,952.95 | | | Buy 3 | Goldman Sachs | 2,914.35 | | | Buy 4 | Guosen Securities | 2,520.92 | | | Buy 5 | CITIC Securities | 2,428.91 | | | Sell 1 | Guotai Haitong Securities Co., Ltd. Headquarters | | 10,209.10 | | Sell 2 | Goldman Sachs (China) Securities Co., Ltd. Shanghai Pudong New Area Century Avenue Securities Business Department | | 5,924.23 | | Sell 3 | CITIC Securities Co., Ltd. Haining Haichang South Road Securities Business Department | | 4,048.08 | | Sell 4 | Huatai Securities Co., Ltd. Suzhou Wuzhong Avenue Securities Business Department | | 3,447.29 | | Sell 5 | Huatai Securities Co., Ltd. Changsha Xiangjiang Middle Road Securities Business Department | | 3,393.09 |
(Source: Securities Times Online)
Source
东方财富网-A股公司Eastern
Part of this Story
Baihua Pharmaceutical sees net sell-off of 313.37 million yuan after hitting daily limit on Shanghai exchange